Return On Equity of Aptose Biosciences Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aptose Biosciences Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • Aptose Biosciences Inc. Return On Equity for the quarter ending 30 Sep 2025 was 169%, a 83% decline year-over-year.
  • Aptose Biosciences Inc. annual Return On Equity for 2024 was 647%.
  • Aptose Biosciences Inc. annual Return On Equity for 2023 was -459%, a 463% decline from 2022.
  • Aptose Biosciences Inc. annual Return On Equity for 2022 was -81%, a 15% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Aptose Biosciences Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 169% -849% -83% 01 Jul 2025 30 Sep 2025
Q2 2025 238% +5922% 01 Apr 2025 30 Jun 2025
Q1 2025 367% +1371% 01 Jan 2025 31 Mar 2025
Q4 2024 647% +1106% 01 Oct 2024 31 Dec 2024
Q3 2024 1017% +1248% 01 Jul 2024 30 Sep 2024
Q2 2024 -5683% -5530% -3613% 01 Apr 2024 30 Jun 2024
Q1 2024 -1004% -898% -847% 01 Jan 2024 31 Mar 2024
Q4 2023 -459% -377% -463% 01 Oct 2023 31 Dec 2023
Q3 2023 -231% -138% -149% 01 Jul 2023 30 Sep 2023
Q2 2023 -153% -72% -88% 01 Apr 2023 30 Jun 2023
Q1 2023 -106% -32% -43% 01 Jan 2023 31 Mar 2023
Q4 2022 -81% -11% -15% 01 Oct 2022 31 Dec 2022
Q3 2022 -93% -39% -73% 01 Jul 2022 30 Sep 2022
Q2 2022 -81% -31% -61% 01 Apr 2022 30 Jun 2022
Q1 2022 -74% -19% -35% 01 Jan 2022 31 Mar 2022
Q4 2021 -71% -17% -32% 01 Oct 2021 31 Dec 2021
Q3 2021 -54% -4% -8.4% 01 Jul 2021 30 Sep 2021
Q2 2021 -51% +8% +13% 01 Apr 2021 30 Jun 2021
Q1 2021 -55% -2% -3% 01 Jan 2021 31 Mar 2021
Q4 2020 -53% +8% +14% 01 Oct 2020 31 Dec 2020
Q3 2020 -50% +60% +55% 01 Jul 2020 30 Sep 2020
Q2 2020 -58% +64% +52% 01 Apr 2020 30 Jun 2020
Q1 2020 -53% +129% +71% 01 Jan 2020 31 Mar 2020
Q4 2019 -62% +133% +68% 01 Oct 2019 31 Dec 2019
Q3 2019 -110% +77% +41% 01 Jul 2019 30 Sep 2019
Q2 2019 -122% +57% +32% 01 Apr 2019 30 Jun 2019
Q1 2019 -183% -47% -35% 01 Jan 2019 31 Mar 2019
Q4 2018 -195% -72% -59% 01 Oct 2018 31 Dec 2018
Q3 2018 -187% 01 Jul 2018 30 Sep 2018
Q2 2018 -179% 01 Apr 2018 30 Jun 2018
Q1 2018 -135% 01 Jan 2018 31 Mar 2018
Q4 2017 -122% 01 Oct 2017 31 Dec 2017

Aptose Biosciences Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 647% +1106% 01 Jan 2024 31 Dec 2024
2023 -459% -377% -463% 01 Jan 2023 31 Dec 2023
2022 -81% -11% -15% 01 Jan 2022 31 Dec 2022
2021 -71% -17% -32% 01 Jan 2021 31 Dec 2021
2020 -53% +8% +14% 01 Jan 2020 31 Dec 2020
2019 -62% +133% +68% 01 Jan 2019 31 Dec 2019
2018 -195% -72% -59% 01 Jan 2018 31 Dec 2018
2017 -122% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.